17.12.2023, 1585 Zeichen

Marinomed: Marinomed Biotech AG has signed a licensing agreement with Favorex, a subsidiary of DKSH and part of the Healthcare Business Unit, to commercialize a Carragelose nasal spray in Malaysia, Myanmar, Thailand and the Philippines. In addition, the European Patent Office has granted a patent covering the use of carrageenans in the prophylactic and therapeutic treatment of SARS-CoV-2 infections. This patent joins several other patents that protect the use of virus-blocking carrageenans against a range of respiratory viruses. Moreover, Marinomed was also able to successfully establish the production of Carragelose lozenges with its new Turkish manufacturing partner Meksmar. Marinomed already supplied first customers with products and plans to further expand the distribution of Carragelose lozenges in the future.
Marinomed Biotech: weekly performance: -2.40%

EVN: The weather in EVN’s three core markets during the 2022/23 financial year was characterised by milder temperatures. Revenue recorded by the EVN Group declined by 7.2% year-on-year to EUR 3,768.7m in 2022/23. This development resulted primarily from a decline in revenue in South East Europe which, in turn, was caused by lower network and energy sales volumes and by the downward trend in wholesale prices. EBITDA recorded by the EVN Group rose by 15.1% year-on-year to EUR 869.0m in 2022/23. Group net result for the 2022/23 financial year equalled EUR 529.7m (previous year: EUR 209.6m).
EVN: weekly performance: 2.95%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (14/12/2023)

Christian Drastil: Wiener Börse Plausch

Silvesterparty Wiener Börse feat. Wolfgang Matejka & Gunter Deuber: Wer den Wiener Markt 2025 wachgeküsst hat (und sehr viel mehr)

Bildnachweis

Aktien auf dem Radar:UBM, Agrana, Zumtobel, Addiko Bank, Austriacard Holdings AG, Palfinger, ATX, ATX Prime, ATX TR, ATX NTR, Bawag, Mayr-Melnhof, RBI, Wienerberger, Lenzing, Rosenbauer, Warimpex, CA Immo, FACC, Wolford, BKS Bank Stamm, Oberbank AG Stamm, VIG, Amag, AT&S, CPI Europe AG, Österreichische Post, voestalpine, Infineon, Merck KGaA, Fresenius Medical Care.

---